Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
10 Hits
Search Condition : Filter (MeSH = Adenocarcinoma, Clear Cell / metabolism)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
JHOC-7(RCB1688)
,
JHOC-9(RCB2226)
61799
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Oncotarget
2016-11-15
Pubmed
Full text
Human and Animal Cells
JHOC-9(RCB2226)
58095
Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
Gynecol Oncol
2019-12-1
Pubmed
Full text
Human and Animal Cells
JHOC-5(RCB1520)
57867
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.
Cancer Lett
2019-10-1
Pubmed
Full text
Human and Animal Cells
JHOC-5(RCB1520)
54755
PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Hum Pathol
2019-4-1
Pubmed
Full text
Human and Animal Cells
JHOC-5(RCB1520)
52067
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Oncol Rep
2017-3-1
Pubmed
Full text
Human and Animal Cells
43853
Hyalinized stroma in clear cell carcinoma of the ovary: how is it formed?
Hum Pathol
2012-11-1
Pubmed
Full text
Human and Animal Cells
OMC-3(RCB0755)
,
JHOC-5(RCB1520)
,
HTOA(RCB0692)
,
JHOS-3(RCB1546)
42511
Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis.
Cancer Lett
2006-9-28
Pubmed
Full text
Human and Animal Cells
38421
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Clin Cancer Res
2011-4-15
Pubmed
Full text
Human and Animal Cells
JHOC-5(RCB1520)
,
JHOC-7(RCB1688)
,
JHOC-8(RCB1723)
,
JHOC-9(RCB2226)
36975
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Mol Carcinog
2016-5-1
Pubmed
Full text
Human and Animal Cells
NIH:OVCAR-3(RCB2135)
18646
Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.
Anticancer Res
2011-4-1
Pubmed